- PRaze
- PR Newswire
- EN
- 2026年9月
PR Newswire EN
2026年9月のプレスリリース
-
PR NewswireEN医療・健康・介護
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast
Yuyu Pharma
-
PR NewswireEN医療・健康・介護
Clinical Psychologist Urges Women to Recognise the Signs of a Dysregulated Nervous System
Mind in Mind Psychology
-
PR NewswireEN医療・健康・介護動画
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
New York Stock Exchange
-
PR NewswireEN小売・販売
COLE HAAN LAUNCHES "COMFORTABLE ANYWHERE" CAMPAIGN STARRING CHRISTIAN SLATER AND JENNY SLATE
COLE HAAN
-
PR NewswireENIT・テクノロジー
AULUMU Wins Yanko Design Best of IFA 2026, Showcases Award-Winning Tech Gear in Berlin
AULUMU
-
PR NewswireENその他サービス
Leifras Continues to Operate Nagoya City's Nagoya Club Activities Human Resources Bank, Addressing Instructor Shortage
LEIFRAS Co., Ltd.
-
PR NewswireEN医療・健康・介護
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
Full-Life Technologies
-
PR NewswireENIT・テクノロジー
SuperX Announces an Update on the Progress of Share Repurchases Program, to Demonstrate Confidence in Long-Term Growth Value
SuperX AI Technology Limited
-
PR NewswireENIT・テクノロジー動画
Hyper3D Launches WorldGen to Turn Single Images into Editable 3D Scenes
Hyper3D
-
PR NewswireENIT・テクノロジー
Mobinet to Deploy Plume Platform for Delivery of Smarter WiFi, Enhanced Security and Better Customer Experience to Subscribers across Mongolia
Plume Design, Inc.
-
PR NewswireENIT・テクノロジー
HR Path Strengthens SAP SuccessFactors Expertise as tts digital HR experts Joins the Group
HR Path
-
PR NewswireEN飲食・食品
Daesang Targets Global Pharmaceutical Amino Acid Market, Building on 70 Years of Fermentation Technology
Daesang Corporation
-
PR NewswireENIT・テクノロジー
LattePanda Launches the LattePanda Mu Ultra: A Micro x86 Compute Module for On-Device AI
LattePanda Team
-
PR NewswireEN医療・健康・介護
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies
Transcenta Therapeutics
-
PR NewswireEN医療・健康・介護
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Kazia Therapeutics Limited
-
PR NewswireEN医療・健康・介護
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
Harbour BioMed